Get started
Author

Krisztina Bogos

Observed names: Bogos Krisztina, Bogos, Krisztina, Dr. Krisztina Bogos, K Bogos, K. Bogos
ORCID: 0009-0003-3719-0944
Observed ORCIDs: 0009-0003-3719-0944, 0000-0003-0532-9430
OpenAlex ID: A5043874137
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
2019 · Luis Paz-Ares, Mikhail Dvorkin, et al. · The Lancet · 2,281
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
2020 · Jonathan W Goldman, Mikhail Dvorkin, et al. · The Lancet Oncology · 688
Identification and Clinical Significance of Circulating Endothelial Progenitor Cells in Human Non–Small Cell Lung Cancer
2006 · Balazs Dome, Jozsef Timar, et al. · Cancer Research · 184
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications
2021 · Anna Schwendenwein, Zsolt Megyesfalvi, et al. · Molecular Therapy — Oncolytics · 138
PDF
The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas
2004 · Judit Moldvay, M. Jackel, et al. · Pathology & Oncology Research · 133
Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study
2022 · Zsolt Megyesfalvi, Nandor Barany, et al. · The Journal of Pathology · 95
PDF
Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy
2008 · Balazs Dome, Jozsef Timar, et al. · Critical Reviews in Oncology/Hematology · 63
High VEGFR-3–positive Circulating Lymphatic/Vascular Endothelial Progenitor Cell Level Is Associated with Poor Prognosis in Human Small Cell Lung Cancer
2009 · Krisztina Bogos, Ferenc Renyi-Vamos, et al. · Clinical Cancer Research · 47
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
2022 · Zoltán Kiss, István Wittmann, et al. · Frontiers in Immunology · 46
PDF
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
2022 · Zoltán Vokó, Zoltán Kiss, et al. · Frontiers in Immunology · 44
PDF
Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
2019 · Krisztina Bogos, Zoltán Kiss, et al. · Frontiers in Oncology · 36
PDF
Role of retinoic receptors in lung carcinogenesis
2008 · Krisztina Bogos, Ferenc Renyi-Vamos, et al. · Journal of Experimental & Clinical Cancer Research · 33
PDF
Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
2021 · Krisztina Bogos, Zoltan Kiss, et al. · Pathology & Oncology Research · 31
PDF
In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancer
2022 · Beáta Szeitz, Zsolt Megyesfalvi, et al. · Clinical and Translational Medicine · 28
PDF
Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program
2022 · Anna Kerpel-Fronius, Zsuzsanna Monostori, et al. · European Radiology · 28
Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
2021 · Lilla Tamási, Krisztian Horvath, et al. · Pathology & Oncology Research · 27
PDF
Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx™ in paraffin-embedded cancer tissues
2006 · Katalin Derecskei, Judit Moldvay, et al. · Pathology & Oncology Research · 22
Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases
2016 · Judit Moldvay, Katalin Fábián, et al. · Pathology & Oncology Research · 19
Lung Cancer in Hungary
2020 · Krisztina Bogos, Zoltán Kiss, et al. · Journal of Thoracic Oncology · 17
PDF
EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits
2022 · Eszter Bencze, Krisztina Bogos, et al. · Pathology & Oncology Research · 14
PDF
Care of patients with non-small-cell lung cancer stage III – the Central European real-world experience
2020 · Milada Zemanova, Robert Pirker, et al. · Radiology and Oncology · 14
PDF
Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study
2025 · Miklós Darida, Gábor Rubovszky, et al. · Frontiers in Oncology · 13
Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant
2022 · Veronika Müller, Lorinc Polivka, et al. · Vaccines · 13
PDF
Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016
2021 · Krisztina Bogos, Zoltan Kiss, et al. · Pathology & Oncology Research · 13
PDF
HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program
2023 · Anna Kerpel-Fronius, Zsolt Megyesfalvi, et al. · European Radiology · 11
PDF
Works count: 126
Citation count: 4,201
H-index: 18
I10-index: 28
Year
Topic
Type